[EVALUATION OF THE DEGREE OF EXPOSURE TO CARBON DISULFIDE. I. ATTEMPTED APPLICATION OF THE INDEX OF ABSORPTION DESCRIBED BY V. VASAK AND CO-AUTHORS UNDER INDUSTRIAL CONDITIONS].

M. Jakubowski

IF: 1

Medycyna Pracy

Abstract:

What problem does this paper attempt to address?

Clinical and Pathology Features of IgA Nephropathy with Active Tubular Interstitial Lesions

Gong Jianguang,Jin Juan,Zhao Li,Li Yiqiao,Zou Wenli,Li Yiwen,He Qiang

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2016.10.002

2016-01-01

Abstract:Objective To investigate the clinical and pathological characteristics of IgA nephropathy (IgAN) in association with active tubular interstitial lesions. Methods 148 patients who were diagnosed as IgAN by renal biopsy and admitted to Zhejiang Provincial People's Hospital from March 2014 to December 2014 were enrolled. They were divided into IgAN with active tubular interstitial lesions group (IgAN?ATIL group, 23 patients) and IgAN without active tubular interstitial lesions group (control group, 125 patients). Clinical and pathological characteristics were retrospectively analyzed. Multivariate logistic regression analysis was used to analyze the influence factors. Results The prevalence of ATIL in 148 IgAN patients was 15.5%. IgAN?ATIL group showed an older average age and more higher proportion of medication history (antibiotics, diuretics, nonsteroidal anti ?inflammatory drugs, etc) than those in control group. There were significant differences in Alb, eGFR, Scr, BUN, 24?hour urinary protein quantity, urinary NGAL and urinary RBC count between two groups (P<0.05, respectively). A moderate of tubulointerstitial lesions of IgAN?ATIL group was shown, while the control group was mainly mild lesions. Multivariate logistic regression analysis showed that age, medication history and the urinary NGAL level were independent risk factors of IgAN ? ATIL. Conclusions IgAN patients with active tubular interstitial lesions had more severe clinical manifestations and chronic interstitial lesions. The age, medication history (antibiotics, diuretics, nonsteroidal anti?inflammatory drugs, etc) and the urinary NGAL level were independent risk factors of IgAN?ATIL.
Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy

Minako Akiyama,Kosuke Shimomura,Hiroshi Yoshimoto,Minako Sako,Makoto Kodama,Keiko Abe,Mariko Gunji,Dedong Kang,Takashi Takaki,Yukihiro Wada,Masayuki Iyoda,Kazuho Honda

DOI: https://doi.org/10.1007/s00428-022-03373-w

Abstract:Intestinal immunity has been closely associated with the pathogenesis and progression of renal diseases, a relationship known as the "gut-kidney axis." To determine the association between immunoglobulin A nephropathy (IgAN) and Crohn's disease (CD), a clinico-pathological study was performed on patients who had IgAN with CD (CD-IgAN) and without CD (NOS-IgAN). We enrolled 29 patients diagnosed with IgAN via renal biopsy at the Tokyo Yamate Medical Center from 2009 to 2017. The patients were divided into CD-IgAN (n = 18) and NOS-IgAN (n = 11) and evaluated for clinical and pathological findings. IgA subclasses and galactose-deficient IgA1 (Gd-IgA1) were examined via immunohistochemistry using formalin-fixed paraffin-embedded sections from renal biopsy. Our results showed no significant difference in the extent of mesangial IgA subclasses or Gd-IgA1 deposition according to the presence or absence of CD. Pathologically, however, those with CD-IgAN had remarkably higher percentage of global glomerulosclerosis and extent of interstitial fibrosis and tubular atrophy (IF/TA) compared to those with NOS-IgAN. Moreover, the extent of macrophage infiltration in the glomerulus and interstitium was significantly higher in CD-IgAN than in NOS-IgAN. Clinically, the CD-IgAN group had significantly worse responsiveness to steroid treatment compared to the NOS-IgAN group. In conclusion, the similar immunological characteristics of deposited IgA molecules in the glomeruli between the CD-IgAN and NOS-IgAN groups might suggest their etiological similarity. However, a renal pathology showing advanced glomerular and tubulointerstitial sclerosis accompanying increased macrophage infiltration and highly resistant clinical features in patients with CD-IgAN suggests that some pathophysiological factors in CD, including abnormal intestinal immunity, may promote and activate the inflammatory process in IgAN via undetermined mechanisms.
Comparison Between Patients with IgA Nephropathy with Minimal Change Disease and Patients with Minimal Change Disease.

Xiao-Wei Li,Shui-Qin Cheng,Shao-Shan Liang,Wei-Bo Le,Cai-Hong Zeng,Jin-Quan Wang,Zhi-Hong Liu

DOI: https://doi.org/10.5414/cn108727

2016-01-01

Clinical Nephrology

Abstract:OBJECTIVE:To compare the clinicopathological characteristics, treatment response, and prognosis between patients with IgAN nephropathy with minimal change disease (MCD-IgAN) and patients with minimal change disease (MCD). METHODS:77 patients with biopsy-proven MCD-IgAN from the Jinling Hospital IgAN Registry and 77 patients with MCD followed up for ≥ 3 years were retrospectively reviewed. RESULTS:MCD-IgAN and MCD patients had similar clinical presentations, both were predominantly young males, the disease mainly manifested as nephrotic syndrome, and the patients rarely presented with microscopic hematuria. Compared with the MCD group, patients with MCD-IgAN had lower levels of baseline serum albumin (p < 0.01) and eGFR (p < 0.05), a higher level of urine n-acetylglucosaminidase (p < 0.01), higher proportion of mesangial hypercellularity (M1), and more severe acute tubulointerstitial lesions in renal pathology (p < 0.01, p < 0.01, respectively). After 8 weeks of corticosteroid therapy, no significant differences were observed in the rate of complete remission, partial remission, and no remission between MCDIgAN and MCD patients (88.3% vs. 90.9%, 10.4% vs. 5.2%, 1.3% vs. 3.9%, p > 0.05). The median time to achieve remission was 4 weeks (range 1 - 24 weeks) and 4 weeks (range 1 - 28 weeks), respectively. No significant difference existed in the efficacy of corticosteroid between the two groups. During 3.96 years (range 3.0 - 8.5 years) of follow-up, no patients in the two groups entered end-stage renal disease (ESRD), only 2 patients (2.6%) with MCD-IgAN had > 50% reduction of eGFR. CONCLUSIONS:MCD-IgAN may be controlled well achieving a comparable clinical outcome as MCD but more frequently necessitates additional immunosuppressive medication.
Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease

Xiao-Wei Li,Shao-Shan Liang,Wei-Bo Le,Shui-Qin Cheng,Cai-Hong Zeng,Jin-Quan Wang,Zhi-Hong Liu

DOI: https://doi.org/10.1007/s40620-015-0242-9

IF: 4.4061

2015-01-01

Journal of Nephrology

Abstract:Background The clinicopathological characteristics, treatment response and long-term outcome of immunoglobulin (Ig)A nephropathy with minimal change disease (MCD-IgAN) are not well defined. Methods Patients with biopsy-proven MCD-IgAN from the Jinling Hospital IgA nephropathy Registry were systematically reviewed and compared with those with IgA nephropathy without minimal change disease (Non-MCD-IgAN). Results We compared data of 247 MCD-IgAN patients and 1,121 Non-MCD-IgAN patients. Compared to Non-MCD-IgAN, MCD-IgAN patients were younger,with male predominance, had higher levels of proteinuria, total cholesterol and estimated glomerular filtration rate (eGFR), lower incidence of hypertension and microhematuria, lower level of serum creatinine, and had less severe glomerular, tubulointerstitial and vascular lesions in renal pathology. In the Non-MCD-IgAN group, 157 patients (14.0 %) reached the renal endpoint and 103 patients (9.2 %) entered end-stage renal disease (ESRD). The 5-,10-, 15- and 20-year cumulative renal survival rates from ESRD, calculated by Kaplan–Meier method, were 95.0, 83.0, 72.9 and 65.4 %, respectively. In the MCD-IgAN group, no patients entered ESRD and only 4 (1.6 %) reached the renal endpoint. Patients with MCD-IgAN had a significantly better renal outcome than Non-MCD-IgAN ( p < 0.01). At multivariate Cox analysis, proteinuria >1.0 g/day, hypertension, eGFR <60 ml/min/1.73 m 2 , hypoproteinemia and hyperuricemia were independent risk factors of renal survival for Non-MCD-IgAN patients [hazard ratio (HR) 3.43, p < 0.001; HR 1.65, p < 0.05; HR 2.61, p < 0.001; HR 2.40, p < 0.001; HR 2.27, p < 0.001, respectively), but not for patients with MCD-IgAN. Conclusions The long-term outcome of patients with MCD-IgAN is significantly better than that of patients with Non-MCD-IgAN.
Clinicopathological Features and Renal Outcomes of IgA Nephropathy with Acute Tubulointerstitial Nephropathy

Wang Lili,Shi Sufang,Liu Lijun,Lv Jicheng,Wang Suxia,Zou Wanzhong,Zhang Hong

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2019.03.001

2019-01-01

Abstract:Objective To evaluate the clinicopathological characteristics and outcomes of IgA nephropathy (IgAN) with acute tubulointerstitial nephropathy (ATIN).Methods Patients who were diagnosed as IgAN with ATIN and IgAN without ATIN by renal biopsy in Peking University First Hospital were enrolled.There were 74 cases of IgAN with ATIN,and seventy-four cases of IgAN without ATIN were enrolled based on stratified sampling (chosen by 1∶ 1).The two groups were well matched with age,gender,follow-up time,mesangial hypercellularity(M),endocapillaryhypercellularity (E),segmental glomerulosclerosis(S),tubular atrophy/interstitial fibrosis(T) and cellular/fibrocellular crescent(C).The clinicopathological characteristics and outcomes of two groups were retrospectively analyzed.A composite end point,defined as 30％ or 50％ estimated glomerular filtration rate (eGFR)decline and end stage renal disease (ESRD) was used.Renal function and proteinuria during follow-up were observed.Renal survival was calculated by Kaplan-Meier survival analysis and risk factors of progression were analyzed by using univariate and multivariate Cox regression models.Results Seventy-four cases of IgAN with ATIN and seventy-four cases of IgAN without ATIN were enrolled.Serum creatinine [(185.6±83.2) μmol/L vs (146.3 ±69.2) μmol/L,P=0.010] and incidence of acute kidney disease (AKD) (31.1％ vs 5.4％,P ＜ 0.001) were higher in IgAN with ATIN group than those in IgAN without ATIN group.Patients in ATIN group received more immunosuppressive treatment (86.5％vs 58.1％,P＜ 0.001).During 1 year after biopsy,mean eGFR increased significantly in IgAN with ATIN group [(39.7+ 14.6) ml· min-1· (1.73 m2)-1 vs (47.2+ 19.9) ml· min-1· (1.73 m2)-1,P=0.017],but mean eGFR was not statistic different in IgAN without ATIN group [(60.0±30.5) ml· min-1· (1.73 m2)-1 vs (59.0±31.7) ml· min-1· (1.73 m2)-1,P=0.567].Median follow-up was 23.0 months in IgAN with ATIN group,and Median follow-up was 30.0 months in IgAN without ATIN group.Incidence of composite end point had no significant differences between two groups.IgAN with ATIN was not the independent risk factor for end point.IgAN patients with ATIN were divided into two groups (with AKD and without AKD),then renal survival rate was higher (Log-rank test,x2=5.293,P=0.021) and the risk for composite end point decreased by 79.2％ (HR=0.208,95％CI 0.046-0.939,P=0.041) in the group with AKD.Conclusions In IgAN,there is a subgroup of patients with the specific pathological phenotype combined with ATIN.Compared with those without AKD,the risk for composite end point of IgAN patients with ATIN and AKD showed a 79.2％ decrease.
Metabolism of the phospholipid precursor inositol and its relationship to growth and viability in the natural auxotroph Schizosaccharomyces pombe

Serafin Fernandez,M. J. Homann,A. Susan,Henry,G. Carman

DOI: https://doi.org/10.1128/jb.166.3.779-786.1986

IF: 3.2

1986-06-01

Journal of Bacteriology

Abstract:Phospholipid metabolism in the fission yeast Schizosaccharomyces pombe was examined. Three enzymes of phospholipid biosynthesis, cytidine diphosphate diacylglycerol synthase (CDP-DG), phosphatidylinositol (PI) synthase, and phosphatidylserine (PS) synthase, were characterized in extracts of S. pombe cells. Contrary to an earlier report, we were able to demonstrate that CDP-DG served as a precursor for PI and PS biosynthesis in S. pombe. S. pombe is naturally auxotrophic for the phospholipid precursor inositol. We found that S. pombe was much more resistant to loss of viability during inositol starvation than artificially generated inositol auxotrophs of Saccharomyces cerevisiae. The phospholipid composition of S. pombe cells grown in inositol-rich medium (50 microM) was similar to that of S. cerevisiae cells grown under similar conditions. However, growth of S. pombe at low inositol concentrations (below 30 microM) affected the ratio of the anionic phospholipids PI and PS, while the relative proportions of other glycerophospholipids remained unchanged. During inositol starvation, the rate of PI synthesis decreased rapidly, and there was a concomitant increase in the rate of PS synthesis. Phosphatidic acid and CDP-DG, which are precursors to these phospholipids, also increased when PI synthesis was blocked by lack of exogenous inositol. The major product of turnover of inositol-containing phospholipids in S. pombe was found to be free inositol, which accumulated in the medium and could be reused by the cell.
Interleukin-1 selectively potentiates bradykinin-stimulated arachidonic acid release from human synovial fibroblasts.

L. Cisar,E. Mochan,R. Schimmel

DOI: https://doi.org/10.1016/0898-6568(93)90086-2

IF: 4.85

1993-07-01

Cellular Signalling

Abstract:
Long-term renal survival and related risk factors of patients with IgA nephropathy:results from a cohort of 1126 cases in a Chinese adult population

LE Wei-bo,LIANG Shao-shan,DENG Kang-ping,HU Yang-lin,ZENG Cai-hong,LIU Zhi-hong

DOI: https://doi.org/10.3969/j.issn.1006-298X.2011.02.001

2011-01-01

Abstract:Objective:To investigate the long-term renal survival rate and related risk factors of progression to renal failure in Chinese adult patients with IgA nephropathy(IgAN) and to quantify the effects of proteinuria during the follow-up on outcome in patients with IgAN.Methodology:The patients with biopsy-proven primary IgAN in the Nanjing Glomerulonephritis Registry were studied.Renal survival and the relationships between clinical parameters and renal outcomes were assessed.Results:1 126 patients were enrolled in this study.The 10,15,and 20-year cumulative renal survival rates,calculated by Kaplan-Meier method,were 85%,76% and 67% respectively.At the time of biopsy,proteinuria>1.0 g/d(HR 3.3,P<0.001),eGFR<60 ml/min per 1.73 m2(HR 2.2,P<0.001),hypertension(HR 2.0,P<0.001),and hyperuricemia(HR 1.8,P=0.002) were the independent risk factors.Multivariate COX analysis showed the time-average proteinuria(TA-P) during follow-up was the most important risk factor of renal failure.The patients with TA-P>1.0 g/d were associated with a 9.8-fold risk than that patients with TA-P<1.0 g/d(P<0.001),and 67.7-fold risk than those with TA-P<0.5 g/d(P<0.001).The patients with TA-P<0.5 g/d were better than those with TA-P between 0.5 and 1.0 g/d(HR 13.1,P<0.001).Conclusion:33% of Chinese adult patients with primary IgAN have progressed to End Stage Renal Disease(ESRD) within 20 years.Four clinical features—higher proteinuria,hypertension,impaired renal function,and hyperuricemia are independent predictors of an unfavorable renal outcome.The basic goal of antiproteinuric therapy for Chinese patients is to lower proteinuria to <1.0 g/d,and the optimal goal is to lower proteinuria to <0.5 g/d.
Long-term Renal Survival and Related Risk Factors in Patients with IgA Nephropathy: Results from a Cohort of 1155 Cases in a Chinese Adult Population

WeiBo Le,ShaoShan Liang,YangLin Hu,KangPing Deng,Hao Bao,CaiHong Zeng,ZhiHong Liu

DOI: https://doi.org/10.1093/ndt/gfr527

IF: 7.1857

2011-01-01

Nephrology Dialysis Transplantation

Abstract:BACKGROUND:We sought to identify the long-term renal survival rate and related risk factors of progression to renal failure in Chinese adult patients with IgA nephropathy (IgAN) and to quantify the effects of proteinuria during the follow-up on outcome in patients with IgAN. METHODS:Patients with biopsy-proven primary IgAN in the Nanjing Glomerulonephritis Registry were studied. Renal survival and the relationships between clinical parameters and renal outcomes were assessed. RESULTS:One thousand one hundred and fifty-five patients were enrolled in this study. The 10-, 15- and 20-year cumulative renal survival rates, calculated by Kaplan-Meier method, were 83, 74 and 64%, respectively. At the time of biopsy, proteinuria>1.0 g/day [hazard ratio (HR) 3.2, P<0.001], estimated glomerular filtration rate (eGFR)<60 mL/min/1.73 m2 (HR 2.6, P<0.001), hypertension (HR 1.9, P<0.001), hypoproteinemia (HR 2.0, P<0.001) and hyperuricemia (HR 2.1, P<0.001) were the independent risk factors. Multivariate Cox analysis showed the time-average proteinuria (TA-P) during follow-up was the most important risk factor of renal failure. Patients with TA-P>1.0 g/day were associated with a 9.4-fold risk than patients with TA-P<1.0 g/day (P<0.001) and 46.5-fold risk than those with TA-P<0.5 g/day (P<0.001). Moreover, patients who achieved TA-P<0.5 g/day benefit much more than those with TA-P between 0.5 and 1.0 g/day (HR 13.1, P<0.001). CONCLUSIONS:Thirty-six percent of Chinese adult patients with IgAN progress to end stage renal disease within 20 years. Five clinical features-higher proteinuria, hypertension, impaired renal function, hypoproteinemia and hyperuricemia-are independent predictors of an unfavorable renal outcome. The basic goal of anti-proteinuric therapy for Chinese patients is to lower proteinuria<1.0 g/day and the optimal goal is to lower proteinuria to <0.5 g/day.
IgA nephropathy with acute kidney disease: Characteristics, prognosis, and causes

Xutong Wang,Zuishuang Guo,Bo Huang,Minhua Xie,Jingjing Ren,Yuze Zhu,Haonan Guo,Yongli Wang,Dan Yu,Junjun Zhang,Linqi Zhang

DOI: https://doi.org/10.1016/j.ejim.2022.05.021

Abstract:Background: The clinical manifestations and prognosis of IgA nephropathy (IgAN) are diverse. Some patients may present with kidney dysfunction lasting shorter than 3 months and meet the acute kidney disease (AKD) criteria. This study aimed to investigate the clinicopathological features, causes and prognosis of newly diagnosed cases of IgAN with AKD. Methods: 1320 IgAN patients diagnosed via kidney biopsy between January 2012 and June 2018 were included in this retrospective study, with a median follow-up period of 35 months. We analyzed the clinicopathological, etiological variables, as well as short-term and long-term prognosis. The main outcome was a composite event of 40% decline in eGFR, kidney failure or death. Results: Incidence of AKD was 8.8% in the newly diagnosed IgAN patients, and was found to be an independent risk factor affecting the short-term (HR, 7.1; 95% CI, 2.3-22.2; P = 0.001) and long-term (HR, 1.8; 95% CI, 1.2-2.6; P = 0.006) prognosis, respectively. The most common cause of AKD was malignant hypertension-related AKD (MHT-AKD; 24.1%), followed by hematuria-related AKD (H-AKD; 12.9%), nephrotoxic-drug-exposure-related AKD (NTDE-AKD; 12.1%) and crescents-related AKD (C-AKD; 11.2%). The patients in AKD group had more severe clinicopathological characteristics and poor short-term and long-term prognosis than non-AKD group. In subgroup analysis, the MHT-AKD had the worst 5 years survival rate, followed by NTDE-AKD and C-AKD, whereas H-AKD had the best survival rate. Conclusions: AKD is not rare among IgAN patients, and is an independent risk factor for short-term and long-term prognosis. IgAN patients with AKD resulting from different causes have different prognosis.
Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: a Meta-Analysis of Randomized Controlled Trials.

Jun Cheng,Xiaohui Zhang,Wen Zhang,Qiang He,Xiaojuan Tao,Jianghua Chen

DOI: https://doi.org/10.1159/000226129

2009-01-01

American Journal of Nephrology

Abstract:Background: Published reports examining the efficacy and safety of glucocorticoids for preserving renal function in immunoglobulin A nephropathy (IgAN) have yielded conflicting results. To systematically evaluate the efficacy and safety of glucocorticoids agents for IgAN, we conducted a meta-analysis of the published randomized controlled trials (RCTs). Methods: MEDLINE, EMBASE, the Cochrane Library and article reference lists were searched for RCTs that compared glucocorticoids with placebo and any other non-immunosuppressive agents for treating IgAN. The quality of the studies was evaluated with the method of the intention-to-treat analysis and allocation concealment, as well as with the Jadad method. Meta-analyses were performed on the outcomes of proteinuria and renal survival and adverse events in patients with IgAN. Results: Seven RCTs involving 386 patients were included in the review. Four RCTs reported renal survival data with Kaplan-Meier survival curves. Overall, glucocorticoid agents had statistically significant effects on improved renal survival (HR 0.20, 95% CI 0.20 to 0.39) and reduction of proteinuria (standardized mean difference SMD, –0.51; 95% CI –0.73 to –0.29) when compared with the control group. Tests for heterogeneity showed no difference in effect among the studies. In general, glucocorticoid agents were well tolerated. Patients receiving glucocorticoids therapy did not have an increased risk of development of type 2 diabetes mellitus, hypertension or Cushingoid adverse effects, while glucocorticoids were associated with a significant increase in the risk of gastrointestinal tract adverse events. Conclusions: The current cumulative evidence suggests that glucocorticoids have statistically significant effects on protecting renal function and reduction of proteinuria in patients with IgAN, but we should be careful for its gastrointestinal tract reaction. In general, glucocorticoids agents are a promising medication and should be investigated further.
Characteristics of IgA nephropathy with minimal change lesions

Xiao-wei LI,Wei-bo LE,Shao-shan LIANG,Shui-qin CHENG,Cai-hong ZENG,Jin-quan WANG,Zhi-hong LIU

DOI: https://doi.org/10.7504/nk2015080406

2015-01-01

Abstract:Objective: To analyze the clinic-pathological characteristics, treatment response and long-term prognosis of Ig A nephropathy with minimal change disease(MCD-IgAN). Methods Patients with biopsy-proven MCD-IgAN from the Ig A nephropathy Registry of Jinling Hospital were systematically reviewed and compared with another 1155 patients with Non-MCDIgAN. Results A total of 306 patients were diagnosed with MCD-IgAN, which accounted for 2.57% of Ig A nephropathy during the same period. Totally 247 cases with complete data were enrolled in this study. Male predominance(67.6%) was observed in patients with MCD-IgAN, with an average age of(27.05 ± 11.03) years at renal biopsy. Initial clinical features included: nephrotic syndrome(81.4%), microhematuria(18.7%), hypertension(19.0%), hyponatremia(27.5%), thrombus(2.4%) and acute kidney injury(8.9%). Pathological data revealed that 34 cases(13.7%) had moderate to severe acute tubulointerstitial lesions and 11 cases(4.5%) had mild chronic tubulointerstitial lesions. After 8 weeks of corticosteroid therapy, a complete remission was attained in 216 patients(87.4%), a partial remission in 21 patients(8.5%), and no remission in 10 patients(4.0%). In MCD-IgAN group, no patients entered end stage renal disease(ESRD) and only 4 patients(1.6%) had greater than 50% reduction of epidermal growth factor receptor(e GFR). In NonMCD-IgAN group, 108 patients(9.4%) entered ESRD and 163 patients(14.1%) had greater than 50% reduction of e GFR. Patients with MCD-IgAN had significantly better renal outcome than those with Non-MCD-IgAN(P 0.05). Conclusion Compared with Non-MCD-IgAN patients, those with MCD-IgAN have better response to corticosteroid therapy and better renal outcome. A greater awareness of this rare entity of Ig A nephropathy needs to be created to facilitate proper diagnosis and treatment.
Clinical and pathological characteristics and prognosis of IgA nephropathy with diffused endocapillary proliferation

Zhou Yang,Zhang Hong,Lü Jicheng

DOI: https://doi.org/10.3969/j.issn.1005-2194.2006.02.015

2006-01-01

Abstract:Objective To investigate the clinical and pathological characteristics and the prognosis of IgA nephropathy with diffused endocapillary proliferation(EPIgAN).Methods To analyse the clinical and pathological data of IgAN patients of Peking University First Hospital during the recent 15 years,and the clinical,pathological and renal survival rate of EPIgAN were compared with that of non-EPIgAN.The prognosis of EPIgAN and its risk factors were analyzed and the effectiveness of corticosteroids was also investigated .Results A total of 920 IgAN patients were included in this study.EPIgAN accounted for 5.1%.Hypertention,heavy proteinuria and edema were more popular in EPIgAN patients than in non-EPIgAN.Cellular crescents was more obvious in EPIgAN,while glomeruler sclerosis and renal interstitial fibrosis was less common.There was no difference between two groups in natural prognosis(Log rank,p=0.52).Diffused endocapillary proliferation was not a risk factor of the IgAN(OR=1.67,95%CI,1.70~4.11,P=0.27).Steroid therapy could reduce proteinuria of EPIgAN,but 5-year renal survival rate was not higher than non-steroid therapy patients.Conclusion Compared to non-EPIgAN patients,EPIgAN patients have more prominent clinical manifestations at biopsy,more active lesions and less chronic lesions in renal histology.Diffused endocapillary proliferation is not a risk factor of IgAN.
Clinical Features Of Iga Nephropathy With Serum Anca Positivity: A Retrospective Case-Control Study

Ya-Zi Yang,Su-Fang Shi,Yu-Qing Chen,Min Chen,Yi-He Yang,Xin-Fang Xie,Rong Zou,Ji-Cheng Lv,Li-Jun Liu,Hong Zhang

DOI: https://doi.org/10.1093/ckj/sfv078

2015-01-01

Clinical Kidney Journal

Abstract:Background: The coexistence of IgA nephropathy (IgAN) and antineutrophil cytoplasmic autoantibodies (ANCAs) is relatively rare. Only a few studies have reported the features of these patients.Methods: We studied the clinical and histological features of 20 ANCA-positive IgAN patients. They were compared with ANCA-negative IgAN patients (n = 40) and ANCA-associated systemic vasculitis (AASV) patients (n = 40) with a randomly selected and matched proportion of crescentic glomeruli. Furthermore, 9 ANCA-positive crescentic IgAN patients out of the 20 cases were compared with two control groups with crescentic nephritis.Results: ANCA-positive IgAN patients showed older age, lower haemoglobin and higher inflammatory indicator levels at baseline, and a higher percentage of general symptoms and pulmonary involvement, compared with ANCA-negative IgAN patients, and were comparable to AASV patients. Histologically, there was a significantly higher percentage of fibrinoid necrosis in glomeruli in ANCA-positive IgAN patients and in AASV patients compared with ANCA-negative IgAN patients (35, 25 and 0%, respectively, P = 0.003). After immunosuppressive therapy, ANCA-positive crescentic IgAN patients were more likely to withdraw from dialysis (75 versus 9.1%, P = 0.03) and not to reach end-stage renal disease within 6 months (11.1 versus 66.7%, P = 0.01) compared with ANCA-negative crescentic IgAN patients.Conclusions: IgAN patients with ANCA positivity showed more severe clinical and histological features when compared with ANCA-negative IgAN patients and were comparable to AASV patients. However, renal prognosis was relatively better in ANCA-positive crescentic IgAN patients after aggressive immunosuppressive therapy in the short term, compared with ANCA-negative patients.
Immune Characteristics of IgA Nephropathy with Minimal Change Disease

Huixian Li,Wanhong Lu,Haiyun Li,Xiaoling Liu,Xue Zhang,Liyi Xie,Ping Lan,Xiaoyang Yu,Yinjuan Dai,Xinfang Xie,Jicheng Lv

DOI: https://doi.org/10.3389/fphar.2021.793511

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:Background: IgA nephropathy (IgAN) has a high degree of heterogeneity in clinical and pathological features. Among all subsets of IgAN, the pathogenesis of IgAN with minimal change disease (MCD-IgAN) remained controversial.Methods: We analyzed the clinical and pathological characteristics of MCD-IgAN patients in a retrospective cohort. Patients diagnosed with IgAN, excluding MCD-IgAN, were randomly selected as controls. Levels of plasma galactose-deficient IgA1 (GdIgA1), IgG autoantibodies against GdIgA1, GdIgA1 deposition in the glomerulus, and inflammatory reactivity of circulating poly-IgA1 complexes to cultured mesangial cells were evaluated.Results: Patients with MCD-IgAN had significantly higher levels of proteinuria and estimated glomerular filtration rate (eGFR), lower levels of albumin and urine blood cells, and milder histological lesions by a light microscope compared to IgAN patients, which bears a resemblance to MCD. Lower levels of GdIgA1 (3.41 ± 1.68 vs. 4.92 ± 2.30 μg/ml, p = 0.009) and IgG antiglycan autoantibodies (23.25 ± 22.59 vs. 76.58 ± 71.22 IU/ml, p < 0.001) were found in MCD-IgAN patients than those in IgAN controls. Meanwhile, weaker fluorescence intensities of both IgA and GdIgA1 were observed in the glomerulus of MCD-IgAN patients compared to those in IgAN patients. Furthermore, poly-IgA1 complexes from MCD-IgAN patients induced weaker inflammatory effects on cultured mesangial cells than those from IgAN patients in vitro.Conclusion: The results demonstrated that MCD-IgAN cases represent a dual glomerulopathy, namely, mild IgAN with superimposed MCD, which furthermore provides substantial evidence for the corticosteroids therapy in MCD-IgAN patients as the guidelines recommended.
A Cumulative Renal Survival Analysis of 495 Cases of IgA Nephropathy

Yan Qin,Xue-wang Li,Hang Li,Lin Duan,Yan Li

2004-01-01

Abstract:OBJECTIVE:To study the long-term outcome of idiopathic IgA nephropathy and analyze its clinical and histological prognostic factors. METHODS:We conducted a retrospective analysis of 495 cases of IgA nephropathy patients in our hospital from 1986 to 2002. Renal survival was analyzed by Kaplan-Meier method, univariate analysis and multivariate Cox regression analysis. RESULTS:The cumulative renal survival rate was 85% at 10 years and 70.9% at 15 years. Univariate analysis found the following parameters at the time of biopsy to be significantly correlated with poor renal survival: serum creatinine > or = 133 micromol/L (P < 0.001), hypertension (P < 0.05), 24-hour urine protein excretion > or = 3 g (P < 0.001), histological subclass V (P < 0.001), and without the history of gross hematuria (P < 0.05). The Cox regression analysis showed that only the presence of hypertension (HR=7.75, 95%CI 1.02 to approximately 2.19) and serum creatinine level (HR=1.49, 95%CI 1.54 to approximately 38.90) were independent prognostic indicators. CONCLUSIONS:The findings in Chinese IgA nephropathy patients are in agreement with the results of many other studies worldwide.
Long-term Outcomes of IgA Nephropathy in China.

Xue Shen,Pei Chen,Muqing Liu,Lijun Liu,Sufang Shi,Xujie Zhou,Jicheng Lv,Hong Zhang

DOI: https://doi.org/10.1093/ndt/gfae252

2024-01-01

Abstract:BACKGROUND AND HYPOTHESIS:The long-term prognosis of IgA nephropathy (IgAN) and the optimal target for proteinuria treatment remain controversial. This study, utilizing a large prospective cohort from China, aims to assess the long-term outcomes of IgAN and to explore the definition of proteinuria remission. METHODS:We enrolled 2 141 patients with biopsy-proven IgAN, all with at least 12 months of follow-up, from a prospective IgAN cohort at Peking University First Hospital. We utilized Kaplan-Meier analysis, Cox regression, and an eGFR slope calculated via a linear mixed model to investigate kidney outcomes. RESULTS:The median (Q1, Q3) baseline proteinuria was 1.26 (0.65, 2.40) g/d, and the estimated GFR was 80 (52, 103) mL/min/1.73m2. After a mean follow-up of 5.8 (±4.4) years, 509 (24%) patients progressed to end-stage kidney disease (ESKD). The median kidney survival time was 12.4 years, the annual event rate of ESKD was 41.1 per 1000 person-years, and the 15-year kidney survival rate was 40%. Time-averaged proteinuria level was strongly associated with kidney failure (adjusted HR: 1.76, 95%CI: 1.65 to 1.88). Restriction cubic spline analysis indicated that the risk of ESKD increases rapidly when time-average proteinuria exceeded 0.5 g/d. There was no significant difference in long-term kidney survival between patients with proteinuria < 0.3 g/d and those with 0.3-0.5 g/d, with both groups demonstrating a better prognosis. CONCLUSION:The long-term outcomes for patients with IgAN under current treatment strategies remain poor, with most progressing to ESKD within 15 years. Patients with time-averaged proteinuria ≥ 0.5 g/d experience worse kidney outcomes, challenging the previous view that proteinuria < 1.0 g/d was associated with a low risk of kidney failure.
Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Jicheng Lv,Hong Zhang,Yang Zhou,Guangtao Li,Wanzhong Zou,Haiyan Wang

DOI: https://doi.org/10.1111/j.1440-1797.2007.00898.x

2008-01-01

Nephrology

Abstract:Aim: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. However, its natural history and risk factors are not well understood. Our aim was to identify the clinical and pathological factors that could predict disease prognosis in Chinese patients. Methods: We studied 204 biopsy-diagnosed IgAN patients, who were followed for an average of 6.1 years (range, 4-15 years). Chronic kidney disease (CKD) classified according to the Kidney Disease Outcomes Quality Initiative practice guidelines. Renal pathological lesions were graded single-blindedly according to the Haas classification. The glomerular filtration rate was estimated by the Modification of Diet in Renal Disease equation for Chinese subjects. Results: Patients with CKD were classified as stage 1 (38.10%), stage 2 (35.40%), stage 3 (13.30%), stage 4 (9.90%) and stage 5 (3.30%). During the follow up, 31 patients had progressed to end-stage renal disease. The renal survival rate following biopsy was 85.1% at the fifth year, and 77.1% at the 10th year. Univariate analysis indicated that patients who were male, had hypertension, proteinuria of more than 1 g/day, renal impairment (estimated glomerular filtration rate, <60 mL/min.1.73 m(2)), and a high histological grading were associated with poor prognosis. Multivariate analysis indicated that the relative risk of renal failure for patients was 3.9 (P = 0.000) for patients with renal impairment, 2.8 (P = 0.019) for patients with hypertension, and 2.0 (P = 0.003) for patients with high histological grading. Conclusion: We described the natural history of IgAN through follow ups of a relatively large cohort of patients. Most patients were biopsied at an early stage; however, the long-term prognosis was still poor. Patients with renal impairment, hypertension and advanced histological involvement had the highest risk for disease progression.
Characterization of patients with IgA nephropathy with and without associated minimal change disease

Wei-Yi Guo,Li-Jun Sun,Hong-Rui Dong,Guo-Qin Wang,Xiao-Yi Xu,Wen-Rong Cheng,Zhi-Rui Zhao,Nan Ye,Yun Liu,Hong Cheng

DOI: https://doi.org/10.3389/fneph.2023.1105933

2023-02-16

Abstract:Introduction: Immunoglobulin A nephropathy (IgAN) presents various clinical manifestations and pathological phenotypes. Approximately 5% of patients with IgAN present with early onset nephrotic syndrome, mild mesangial lesions, and diffuse foot process effacement of podocytes, which resemble minimal change disease (MCD). These patients are defined as MCD-IgAN. Whether MCD-IgAN is a special type of IgAN or simply MCD accompanied by IgA deposition remains controversial. Methods: A total of 51 patients diagnosed with MCD-IgAN at Beijing Anzhen Hospital from January 2010 to September 2022 were recruited. The clinical and pathological characteristics of IgA-MCD were analyzed. Patients with IgAN but without MCD (non-MCD-IgAN) and healthy participants were enrolled as controls. Galactose-deficient immunoglobulin A1 (Gd-IgA1) and complement C3 were detected both in the circulation and in renal tissues. Results: We found that the levels of serum Gd-IgA1 were lower in participants with MCD-IgAN than in those with non-MCD-IgAN, but higher than in healthy participants. Gd-IgA1 was rarely deposited in the glomeruli of participants with MCD-IgAN, with a positive rate of only 13.7% (7/51); in contrast, the positive rate in participants with non-MCD-IgAN was 82.4% (42/51). Among renal Gd-IgA1-positive patients, Gd-IgA1 and immunoglobulin A (IgA) colocalized along the glomerular mesangial and capillary areas. Interestingly, we found that the circulating levels of complement C3 were significantly higher in participants with MCD-IgAN than in participants with non-MCD-IgAN. In addition, the intensity of C3c in glomeruli in participants with MCD-IgAN was significantly weaker than in participants with non-MCD-IgAN. Conclusions: Our study suggests that, in MCD-IgAN, most of the IgA that is deposited on glomeruli is not the same pathogenic Gd-IgA1 as found in general IgAN. Complement activation both in the circulation and in the renal locality was much weaker in MCD-IgAN than in non-MCD-IgAN. Our study suggests that IgAN with MCD might be MCD with coincidental IgA deposition.
Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients

Gaiqin Pei,Aiya Qin,Lingqiu Dong,Siqing Wang,Xiang Liu,Dandan Yang,Jiaxing Tan,Xiaoyuan Zhou,Yi Tang,Wei Qin

DOI: https://doi.org/10.3389/fendo.2022.877794

IF: 6.055

2022-06-20

Frontiers in Endocrinology

Abstract:Background: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To clarify these issues, we conducted this study. Methods: A total of 1146 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018.The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Then, patients were divided into the high TG/HDL group (TG/HDL ≥ 1.495, N=382) and the low TG/HDL group (TG/HDL-C < 1.495, N=764) based on the optimal cut-off value of the TG/HDL-C using receive operating curve. Cox proportional hazard models and Kaplan–Meier curves were used to evaluate the renal outcomes of IgAN. Results: The median age of the patients was 33 (26-42) years, and 44.5% were men. By correlation analysis, we found that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.250, P < 0.001) but positively correlated with proteinuria (r = 0.230, P < 0.001), BMI (r=0.380, P<0.001) and serum uric (r =0.308, P < 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.987; 95% CI, 1.527-2.587; P <0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 1.610; 95% CI, 1.203-2.154; P =0.001). During a median follow-up period of 54.1 (35.6-73.2) months, a high TG/HDL ratio was strongly associated with worse renal survival in IgAN patients (log-rank: P < 0.001). Multivariate Cox analysis demonstrated that a high TG/HDL-C ratio (HR 1.775, 95% CI 1.056-2.798; P =0.029) was an independent predictive marker to ESRD. Conclusion: In this study, we addressed the importance of TG/HDL-C ratio as a predictive marker for IgAN progression.

endocrinology & metabolism

[EVALUATION OF THE DEGREE OF EXPOSURE TO CARBON DISULFIDE. I. ATTEMPTED APPLICATION OF THE INDEX OF ABSORPTION DESCRIBED BY V. VASAK AND CO-AUTHORS UNDER INDUSTRIAL CONDITIONS].

Clinical and Pathology Features of IgA Nephropathy with Active Tubular Interstitial Lesions

Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy

Comparison Between Patients with IgA Nephropathy with Minimal Change Disease and Patients with Minimal Change Disease.

Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease

Clinicopathological Features and Renal Outcomes of IgA Nephropathy with Acute Tubulointerstitial Nephropathy

Metabolism of the phospholipid precursor inositol and its relationship to growth and viability in the natural auxotroph Schizosaccharomyces pombe

Interleukin-1 selectively potentiates bradykinin-stimulated arachidonic acid release from human synovial fibroblasts.

Long-term renal survival and related risk factors of patients with IgA nephropathy:results from a cohort of 1126 cases in a Chinese adult population

Long-term Renal Survival and Related Risk Factors in Patients with IgA Nephropathy: Results from a Cohort of 1155 Cases in a Chinese Adult Population

IgA nephropathy with acute kidney disease: Characteristics, prognosis, and causes

Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: a Meta-Analysis of Randomized Controlled Trials.

Characteristics of IgA nephropathy with minimal change lesions

Clinical and pathological characteristics and prognosis of IgA nephropathy with diffused endocapillary proliferation

Clinical Features Of Iga Nephropathy With Serum Anca Positivity: A Retrospective Case-Control Study

Immune Characteristics of IgA Nephropathy with Minimal Change Disease

A Cumulative Renal Survival Analysis of 495 Cases of IgA Nephropathy

Long-term Outcomes of IgA Nephropathy in China.

Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Characterization of patients with IgA nephropathy with and without associated minimal change disease

Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients